Astrid Bratvedt - Navamedic ASA Chief Officer

All Insiders . Norway . 
Stock . Navamedic ASA . Stakeholders . Insider . Astrid Bratvedt
NAVA Stock  NOK 24.00  0.50  2.13%   

Insider

Astrid Bratvedt is Chief Officer of Navamedic ASA
Phone47 67 11 25 40
Webhttps://www.navamedic.com

Navamedic ASA Management Efficiency

The company has return on total asset (ROA) of 0.0633 % which means that it generated a profit of $0.0633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.073 %, meaning that it generated $0.073 on every $100 dollars invested by stockholders. Navamedic ASA's management efficiency ratios could be used to measure how well Navamedic ASA manages its routine affairs as well as how well it operates its assets and liabilities.
Navamedic ASA has accumulated 44.8 M in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Navamedic ASA has a current ratio of 1.15, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Navamedic ASA until it has trouble settling it off, either with new capital or with free cash flow. So, Navamedic ASA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Navamedic ASA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Navamedic to invest in growth at high rates of return. When we think about Navamedic ASA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Stefan HanssonMutasKitron ASA
57
Lars NilssonKitron ASA
59
Mike FarbelowMedistim ASA
N/A
Margrethe HaugeGoodtech
52
Ole EiksundMedistim ASA
56
Hans ThomassenKitron ASA
58
Cathrin NylanderKitron ASA
56
Carsten ChristensenKitron ASA
57
Kristoffer AsklovKitron ASA
46
Patricia KellyPhotocure
N/A
Helge BorslidMedistim ASA
N/A
Lucy WabakkenPCI Biotech Holding
N/A
Zygimantas DirseKitron ASA
43
Stian HaugenKitron ASA
47
Cindy KaffaiMedistim ASA
N/A
Kari KrogstadMedistim ASA
59
Thomas JakobsenMedistim ASA
54
Magnus DueGoodtech
N/A
Ole RobsrudMedistim ASA
N/A
Kari MDPhotocure
N/A
Hge WetterhusMedistim ASA
59
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway. NAVAMEDIC ASA operates under Healthcare Products classification in Norway and is traded on Oslo Stock Exchange. It employs 26 people. Navamedic ASA (NAVA) is traded on Oslo Stock Exchange in Norway and employs 28 people.

Management Performance

Return On Equity0.073
Return On Asset0.0633

Navamedic ASA Leadership Team

Elected by the shareholders, the Navamedic ASA's board of directors comprises two types of representatives: Navamedic ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Navamedic. The board's role is to monitor Navamedic ASA's management team and ensure that shareholders' interests are well served. Navamedic ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Navamedic ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lars Hjarrand, Chief Financial Officer
PerAnders Elvertro, Chief Commercial Officer, Head of Regulatory Affairs and Drug Safety
Astrid Bratvedt, Chief Officer
Jostein Davidsen, Director
Mattias Hartmann, Marketing Director
Kathrine Andreassen, Chief Executive Officer
Narve Reiten, Director
Inger Solberg, Director
Mattias Haartman, Marketing & Sales Director
Ole Eriksen, Chief Officer
Magnus Emmoth, Chief Executive Officer of Navamedic Medtech AB
Terje Bakken, Chairman of the Board
Cheng Lu, Director

Navamedic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Navamedic ASA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.073
Return On Asset0.0633
Profit Margin0.03 %
Operating Margin0.1 %
Current Valuation578.31 M
Shares Outstanding16.35 M
Shares Owned By Insiders41.56 %
Shares Owned By Institutions14.08 %
Price To Earning9.39 X
Price To Book3.04 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Navamedic Stock

Navamedic ASA financial ratios help investors to determine whether Navamedic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Navamedic with respect to the benefits of owning Navamedic ASA security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY